Bacillus cereus endophthalmitis following intravitreous bevacizumab injection

Ophthalmic Surgery Lasers and Imaging

Volumn 39, Issue 2, 2008, Pages 153-154

  Kopel, Andrew C ^a   Carvounis, Petros E ^a   Holz, Eric R ^a,b  

^a CULLEN EYE INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CEFTAZIDIME; GATIFLOXACIN; VANCOMYCIN; ANGIOGENESIS INHIBITOR; ANTIINFECTIVE AGENT; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

AGED; ARTICLE; BACILLUS CEREUS; CASE REPORT; CLINICAL FEATURE; ENDOPHTHALMITIS; HUMAN; HUMAN TISSUE; LIGHT; MALE; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION; VISION; VITREOUS BIOPSY; BACTERIAL EYE INFECTION; BACTERIAL INFECTION; BLINDNESS; DRUG ANTAGONISM; DRUG COMBINATION; INJECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; RETINA MACULA DEGENERATION; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

AGED; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; BACILLUS CEREUS; BLINDNESS; CEFTAZIDIME; CHOROIDAL NEOVASCULARIZATION; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; VANCOMYCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 42949138249     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20080301-10     Document Type: Article

References (4)